Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.
Serial metastasis-directed radiotherapy extended time off systemic therapy while maintaining favorable progression-free and overall survival in patients with oligometastatic clear-cell renal cell ...
If you have seen the movie Inside Out, you might already be familiar with the concept of internal family systems, or IFS, therapy. Developed by Dr. Richard Schwartz in the 1980s, IFS is a model of ...
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback